(Q34510750)

English

Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vasc

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vasc (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Harry J. G. M. Crijns

6

object named as

Crijns HJ

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Diercks GF

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Janssen WM

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

van Boven AJ

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Bak AA

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

de Jong PE

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

van Gilst WH

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

635-638

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Microalbuminuria as predictor of increased mortality in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Endothelial dysfunction precedes development of microalbuminuria in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Microalbuminuria: An Early Marker of Renal Involvement in Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901042-0

7 January 2021

Identifiers

10.1016/S0002-9149(00)01042-0

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34510750&oldid=1576606516"